U.S. Conference on AIDS Focuses on Epidemic in the South
- Details
- Category: HIV Treatment
- Published on Wednesday, 11 September 2013 00:00
- Written by Liz Highleyman
The annual U.S. Conference on AIDS (USCA 2013), sponsored by the National Minority AIDS Council, took place this week in New Orleans, highlighting the burgeoning HIV epidemic in the southern states. Other themes included the Affordable Care Act, HIV prevention, aging, and fighting HIV stigma and criminalization.
IAS 2013: HIV May Be Present in Semen Despite Undetectable Blood Viral Load
- Details
- Category: HIV Sexual Transmission
- Published on Thursday, 22 August 2013 00:00
- Written by Liz Highleyman
Gay men with HIV can shed the virus in their semen even when they are on antiretroviral therapy (ART) with fully suppressed blood plasma viral load, according to a longitudinal French study presented at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur.

IAS 2013: Strategies to Detect and Treat Gay Men with Acute HIV Infection
- Details
- Category: HIV Prevention
- Published on Wednesday, 14 August 2013 00:00
- Written by Roger Pebody
The detection and control of acute (very recent) HIV infection may be a powerful HIV prevention measure for epidemics in men who have sex with men (MSM), Eugène Kroon of the Thai Red Cross AIDS Research Center reported at a late-breaker session at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur. Immediate HIV treatment was associated with rapid falls in viral load and sustained behavior change.

New PEP Guidelines Recommend 3-Drug ART After Occupational HIV Exposure
- Details
- Category: Post-exposure Prophylaxis (PEP)
- Published on Wednesday, 14 August 2013 00:00
- Written by Liz Highleyman
The U.S. Public Health Service this month released updated guidelines for post-exposure prophylaxis (PEP) after occupational exposure in healthcare settings to blood or other body fluids that may contain HIV. The new recommendations call for immediately starting a 4-week regimen containing at least 3 antiretroviral drugs.

IAS 2013: Combination Prevention Trial Shows Drop in HIV Incidence, Increase in Testing
- Details
- Category: HIV Prevention
- Published on Thursday, 01 August 2013 00:00
- Written by Gus Cairns
Results from Project ACCEPT, a pioneering HIV prevention trial comparing the effects of mobile HIV testing, community mobilization, and enhanced support for people with HIV, versus standard voluntary counseling and testing, were announced at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention in Kuala Lumpur.

HIV/AIDS Topics 





























